AEGiS-Reuters: World Bank Offers Russia $150 Mln for AIDS Fight

Reuters, Ltd.Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.
Click here to return to Reuters main menu


DonateNow


World Bank Offers Russia $150 Mln for AIDS Fight

Reuters NewMedia - Thursday November 16, 2000
Tara FitzGerald


MOSCOW (Reuters) - The World Bank said on Thursday it was negotiating a $150 million loan with Russia to help fight what a UN official has called the world's highest AIDS web growth rate.

"This is really the time for action, particularly because AIDS is a serious problem among young people and so it's really a problem for Russia's future," World Bank country director for Russia, Michael Carter, told reporters.

Russian and foreign experts have warned the government that the spread of the disease could reach catastrophic proportions in Russia unless officials take quick action to reduce runaway growth rates.

"The World Bank is very pleased that we are able to work on (an AIDS) project that we will be supporting through a substantial loan of about $150 million," Carter said.

"We hope that the government will be ready to negotiate this loan early in the new year so we can provide support through that loan to the government's (AIDS) programme," Carter said.

The joint United Nations Programme on HIV/AIDS (UNAIDS) estimated the number of HIV and AIDS sufferers in Russia to be 130,000 at the end of last year. But there is broad agreement that cases are significantly under-reported.

Arkadiusz Majszyk, UNAIDS representative in Russia, said on Wednesday Russia had the world's highest growth rate for AIDS. And UNAIDS called on donors to allocate at least $20 million over the next three years to stem the epidemic.

"Russia in a sense is fortunate in that AIDS is still at an early stage," the World Bank's Carter said.


001116
RE001117


Copyright © 2000 - Reuters, Ltd. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.   Contact Reuters.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .